Spots Global Cancer Trial Database for Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy
Official Title: MRI Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
Study ID: NCT03585660
Conditions
Study Description
Brief Summary: The purpose of the proposed research is to test and validate a Risk Map decision-support system (DSS) for prostate cancer Magnetic Resonance Imaging (MRI) interpretation and identification of clinically significant tumor site(s).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
University of Chicago Medical Center, Chicago, Illinois, United States
Contact Details
Name: Aytekin Oto, MD
Affiliation: University of Chicago
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
